F 0644 Coordinate assessments with the pre-admission screening and resident review program; and referring for services as needed. Level of Harm - Minimal harm or potential for actual harm **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 44418
Residents Affected - Few Based on record review and interview, the facility failed to refer a resident with a diagnosed mental disorder to the appropriate state-designated authority for Level II PASARR (Preadmission Screening and Resident Review) evaluation and determination for 1 (#15) of 3 (#15, #32, #49) residents investigated for PASARR in
a final sample of 47 residents.
Findings:
Review of Resident #15's electronic medical record (EMR) revealed she was admitted to the facility on [DATE REDACTED] with diagnoses that included in part, bipolar disorder and major depressive disorder.
Review of Resident #15's Level I PASARR dated 10/07/2022 revealed in part Section III: Mental illness, Question #1 Do you suspect the applicant has, or has the applicant been diagnosed as having a mental illness? Including mental disorders that may lead to chronic disability . schizophrenia, schizoaffective disorder, delusional disorder, other psychotic disorder, bipolar disorder, major depressive disorder .Bipolar disorder was not checked.
Further review of Resident #15's records revealed no evidence that a Level II PASARR had been submitted to the appropriate state-designated authority after Resident #15 had a newly identified mental disorder of bipolar disorder, with an onset date of 10/10/2022.
On 05/20/2025 at 3:10 p.m., an interview and record review was conduct with S5SSD. After review of a psychiatric progress note dated 10/09/2022 for Resident #15, S5SSD confirmed the resident had a qualifying Level II diagnosis of bipolar psychosis. S5SSD confirmed a request for a Level II screening was not submitted for Resident #15. She stated the request for a Level II screening should have been submitted.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER TITLE (X6) DATE REPRESENTATIVE'S SIGNATURE
FORM CMS-2567 (02/99) Event ID: Facility ID: If continuation sheet Previous Versions Obsolete Page 1 of 21 195460 Department of Health & Human Services Printed: 08/26/2025 Form Approved OMB Centers for Medicare & Medicaid Services No. 0938-0391
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A. Building 195460 B. Wing 05/21/2025
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Belle Teche Nursing & Rehabilitation Center 1306 W Admiral Doyle Dr New Iberia, LA 70560
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)